Evidence map›Paper›PMID 37152880›Full record

ArticleActa endocrinologica (Bucharest, Romania : 2005)

ATYPICAL CARCINOID OF THE LARYNX AND MULTIFOCAL METASTASES.

P Soczomski, B Szcześniak-Kłusek, B Jurecka-Lubieniecka, J Krajewska, B Jarząb

Open access · greenAbstract readCase Reports
In one paragraph

Article in Acta endocrinologica (Bucharest, Romania : 2005). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 2 countries.

P SoczomskiDept. of Nuclear Medicine and Endocrine Oncology, "Maria Sklodowska-Curie" National Research Institute of Oncology Gliwice Branch, Gliwice, Poland.
B Szcześniak-KłusekDept. of Neoplasm Pathology, "Maria Sklodowska-Curie" National Research Institute of Oncology Gliwice Branch, Gliwice, Poland.
B Jurecka-LubienieckaDept. of Nuclear Medicine and Endocrine Oncology, "Maria Sklodowska-Curie" National Research Institute of Oncology Gliwice Branch, Gliwice, Poland.
J KrajewskaDept. of Nuclear Medicine and Endocrine Oncology, "Maria Sklodowska-Curie" National Research Institute of Oncology Gliwice Branch, Gliwice, Poland.
B JarząbDept. of Nuclear Medicine and Endocrine Oncology, "Maria Sklodowska-Curie" National Research Institute of Oncology Gliwice Branch, Gliwice, Poland.
National Institute of Oncology · HU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neuroendocrine carcinoma (NEC) of the larynx is the most frequent neuroendocrine neoplasm of the head and neck and the most common nonsquamous carcinoma of the larynx. It usually occurs in the supraglottic area, in smoking men. We report a case of a 58-year-old woman with no history of smoking who presented with an atypical carcinoid, arising in the right piriform sinus of the larynx. During the 5-year follow-up, the patient developed metastases in the lymph nodes, palatine tonsils, parotid glands, breasts and skin. For this reason the patient underwent several surgical procedures, radiotherapy and eventually was qualified for chemotherapy. Our case shows that NEC of the larynx can have an atypical presentation. The diagnosis requires careful pathological evaluation with immunohistochemistry and a wide spectrum of imaging. The serum concentration of chromogranin A seems to be not useful in the diagnosis and follow-up of laryngeal NEC.

Indexed as

atypical carcinoidcase reportlaryngeal tumormetastasesneuro-endocrine cancerneuroendocrine neoplasm

Identifiers

PMID37152880
PMCPMC10162816
OpenAlexW4367724962

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.